News

AddToAny

Google+ Facebook Twitter Twitter

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

At a glance

  • Up to one in 10 older adults experience symptoms of restless leg syndrome.
  • The team created a dataset with more than 100,000 patients and over 1.5 million unaffected controls.
  • They identified over 140 new genetic risk loci, increasing the number known eight-fold to 164, including three on the X chromosome.

 

Restless leg syndrome can cause an unpleasant crawling sensation in the legs and an overwhelming urge to move them. Some people experience the symptoms only occasionally, while others get symptoms every day.

Despite the condition being relatively common – up to one in 10 older adults experience symptoms, while 2%–3% are severely affected and seek medical help – little is known about its causes.

Previous studies had identified 22 genetic risk loci – regions of our genome that contain changes associated with increased risk of developing the condition. But there are still no known biomarkers to objectively diagnose the condition.

To explore the condition further, an international team pooled and analysed data from three genome-wide association studies that compared the DNA of patients and healthy controls.

By combining the data, the team was able to create a powerful dataset with more than 100,000 patients and over 1.5 million unaffected controls.

The team identified over 140 new genetic risk loci, increasing the number known eight-fold to 164, including three on the X chromosome. The researchers found no strong genetic differences between men and women.

bit.ly/4e4MiWZ

Image Credit | Science Photolibrary

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Chromosomes with telomeres - CREDIT-SPlibrary

Telomere findings may offer insights

A new study shows that an enzyme called PARP1 is involved in repair of telomeres – the lengths of DNA that protect the tips of chromosomes – and that impairing this process can lead to telomere shortening and genomic instability that can cause cancer.

Top